iHub My Stocks Activity
Ticker Buzz Cloud
Most Followed Members
Data Tools >
Price & News Alerts
Markets in 3D
More Tools >
My Image Gallery
Personal Finance Q&A
Cannabix Technologies Inc. (BLOZF)
Add BLOZF Price Alert
Search This Board:
8/23/2017 7:34:23 AM
- Board type:
- Posts Today:
Cannabix Technologies Inc.
formerly West Point Resources Inc.
And is a Vancouver, B.C. based company
Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.
Cannabix Technologies Inc. has
Worldwide Rights to
Partial ovoidal FAIMS electrode"
from the University of Florida
Rights for 10 Years after 1st Product sold
It Blocks Out Unwanted Molecules
Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost
Cannabix Technologies' Inc. common shares trade on
Canadian Securities Exchange
US OTC Pinksheets
European Frankfurt Exchange
US Patent Application
Canada Patent Application
Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana. Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions. Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing
CSE:BLO Pinksheets: BLOZF
Issued and Outstanding
(as of Janurary 31, 2016)
Warrants Issued but not Exercised 5,634,325
Options Issued but not Exercised 8,961,300
IF a Patent is Issued
another 5M Shares
Fully Diluted w/Warrants, w/Options and w/Patent 5M Shares IF ISSUED
TOTAL DILUTED 105,690,101
Cannabix Corporate Video
Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc. Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development. Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.
Dr. Raj Attariwala, MD, PhD., Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL). Dr. Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver. He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products. Dr. Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.
Dr. Bruce Goldberger, PhD, Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida. Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.
Richard A. Yost Ph.D., Scientific Advisor
Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.
Jared Boock Ph.D,
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.
Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).
Rav Mlait, MBA – CEO, Director
Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.
Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.
Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge.
Andrew Davies, Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.
Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016). Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine.
BLOZF Detailed Quote
BLOZF News: MJAC 2017 - Speaker Update - Investing In The U.S. Cannabis Market
08/22/2017 01:27:13 AM
BLOZF News: Cannabix Technologies Develops Beta 3.0 Marijuana Breathalyzer and Provides Update
07/31/2017 08:00:00 AM
BLOZF News: Cannabix Technologies Adds Dr. David Hasman to Initiate Marijuana Breathalyzer Trials in British Columbia
05/25/2017 08:30:00 AM
BLOZF News: Live Testing with Cannabix Marijuana Breathalyzer Shows Excellent Sensitivity for THC and Related Metabolites
03/27/2017 08:30:00 AM
Post New Msg
My Stocks (132)
Cannabix Technologies Develops Beta 3.0 Marijuana Breathalyzer and
08/01/17 09:16:11 PM
Cannabix is developing its FAIMS- (field asymmetric waveform
05/25/17 08:41:48 AM
Another GREAT post Shell! Thanks - We have the
08/23/17 07:34:23 AM
sure its needed. what you just said is
08/23/17 03:48:53 AM
THAT WAS GREAT SHELL
08/22/17 04:42:50 PM
It's august. Look at the blue chips.
08/22/17 03:26:06 PM
Maybe because its a Canadian company in British
08/22/17 03:01:31 PM
I am surprised this isn't on more American
08/22/17 02:48:50 PM
finally he gets it!!! Welcome to reality!
08/22/17 02:32:45 PM
In my View, This is one of those
08/22/17 01:29:50 PM
adding new substances will only slow down the
08/22/17 04:48:11 AM
THE PILLARS OF CREATION
08/22/17 01:14:27 AM
Yes AMG - Thank You !! All
08/21/17 09:25:05 PM
All Controlled Substances
08/21/17 09:03:43 PM
This is not "just pot" this is controlled
08/21/17 07:34:33 PM
Thanks, if this one works out, mars is
08/21/17 05:34:37 PM
After the eclipse today I think Mars is
08/21/17 05:25:05 PM
You are correct (BLO/BLOZF). Canadian/USA alliance. Welcome to
08/21/17 05:03:15 PM
So if you remember I was joking about
08/21/17 04:46:10 PM
Now there's a reference I can relate to!!
08/21/17 02:27:30 PM
The Path Of Totality - Here Come The Rooster.
08/21/17 01:25:53 PM
Awsome video ! Thank you Shell
08/21/17 06:37:26 AM
yes that would be a wistimate for sure.
08/21/17 06:25:16 AM
08/20/17 08:57:52 PM
A look back at the birth of the
08/20/17 06:39:42 PM
$37 plus a split would be a heck
08/20/17 06:00:00 PM
Back at ya on the breathtec device being
08/20/17 05:48:52 PM
Cannabix Will Eclipse The Competition.
08/20/17 02:05:24 PM
Yep. One has to look at the current
08/19/17 12:37:32 PM
And could happen in a shorter period than
08/19/17 10:09:36 AM
I think $37 can be done • Even
08/19/17 10:03:04 AM
Human Hepatocyte Metabolism of Novel Synthetic Cannabinoids MN-18
08/19/17 09:02:52 AM
i wouldnt call it guesstimate id call it
08/19/17 07:29:49 AM
Every new disease detection option they add to
08/19/17 07:27:27 AM
congrats! i hope we all get rich one
08/19/17 07:23:59 AM
i just cant wait to see what happens
08/19/17 07:23:09 AM
Wojcik, thank heaven there is somebody in my
08/18/17 05:33:29 PM
- You have been kicking the Old
08/18/17 05:28:42 PM
Tick Tock! As an old fart, time is
08/18/17 05:06:39 PM
If the stock never broke .50 I still
08/18/17 04:51:42 PM
So you are rooting for the stock to
08/18/17 04:30:52 PM
50 cents is resistance just like ive said.
08/18/17 04:10:55 PM
How do you like dem Apples
08/18/17 01:22:54 PM
Apple is 158 $ per share
08/18/17 01:22:25 PM
yes. the share structure.
08/18/17 12:03:46 PM
HIYOOOO! My 2 Cents On Stock Picks.
08/18/17 10:01:06 AM
Perhaps I'm naive, but please explain why a
08/18/17 09:40:01 AM
a thc breathalyzer being available siginificantly earlier than
08/18/17 08:56:38 AM
Whew! No fluffy PRs today. Might
08/18/17 08:27:40 AM
Still beating the Blo vs Breath drum? I
08/17/17 11:08:13 PM
Fair not to agree with that statement... could
08/17/17 09:32:01 PM
I think the breathtec investors might be coming
08/17/17 08:32:45 PM
Post New Msg
My Stocks (132)
© 2017 InvestorsHub.Com, Inc.
Terms of Service
Advertise With Us
Stock Market 101
Investor Help Forum
Personal Finance Q&A
iHub on Facebook
iHub on Twitter
iHub iPhone/iPad App
iHub Android App
iHub BlackBerry App